Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT00401856
Eligibility Criteria:
Inclusion Criteria:
* Stable patients with an established diagnosis of cardiomyopathy as assessed by history, examination and typical ECG/Echo findings who are on maximally tolerated doses of appropriate drugs with no changes being made to the prescription in the 2 months preceding the start of the trial.
Exclusion Criteria:
* Patients already established on treatment with an aldosterone antagonist
* Patients with contraindications to eplerenone (hyperkalaemia, renal failure)
* Critically ill patients requiring respiratory and/or circulatory support
* Pacemaker or ICD
* Implanted ferromagnetic cerebrovascular clips
* Pregnant women (precautionary only)
* Intolerance of confined spaces
* Inability to lie supine for 60 minutes
* Unwilling or unable to give written informed consent
* Atrial fibrillation or ventricular bigemini.
* Any contraindication to CMR.
* Recent MI
* HCM patients who have received surgical/alcohol ablation treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00401856
Study Brief:
Protocol Section:
NCT00401856